Page 2 - Cleveland Diagnostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cleveland diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cleveland Diagnostic Today - Breaking & Trending Today

Cleveland Diagnostics, Inc. Raises Over $19 Million in Financing

Posted on
196
Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that it has closed a Series D round of $17.4 million. The round was led by LYFE Capital, with participation from existing investors including Cleveland Clinic and others. Following the close of the round, the company received a term sheet for a $2M convertible note, expected to close shortly. Funds raised will be used to expand commercialization of IsoPSA the company’s first diagnostic test, designed to enhance early detection of prostate cancer as well as to expand internal infrastructure and operations to support platform development for other tests, including breast and lung cancer. ....

United States , Arnon Chait , Bob Rochelle , Erica Klein , Kidney Institute , Kidney Institute At Cleveland Clinic , Cleveland Diagnostics Inc , Cleveland Diagnostics , Cleveland Clinic , Glickman Urological , Cleveland Diagnostic , Solvent Interaction Analysis , ஒன்றுபட்டது மாநிலங்களில் , பாப் ரோசெல் , எரிகா க்ளீன் , கிட்நீ நிறுவனம் , கிட்நீ நிறுவனம் இல் கிளீவ்லேண்ட் சிகிச்சையகம் , கிளீவ்லேண்ட் பரிசோதனை இன்க் , கிளீவ்லேண்ட் பரிசோதனை , கிளீவ்லேண்ட் சிகிச்சையகம் , கிலிக்க்மன் சிறுநீரக , கிளீவ்லேண்ட் கண்டறியும் , கரைப்பான் தொடர்பு பகுப்பாய்வு ,

Cleveland Diagnostics raises more than $19 million in financing

Cleveland Diagnostics raises more than $19 million in financing
Print
Cleveland Diagnostics Inc., a clinical-stage company that is developing diagnostic tests for the early detection of cancers, said it has closed a Series D financing round of $17.4 million.
The round was led by LYFE Capital, with participation from existing investors including Cleveland Clinic and others, Cleveland Diagnostics said in a news release issued Tuesday, Feb. 9. Following the close of the round, the company said in the release, it received a term sheet for a $2 million convertible note, which is expected to close shortly.
Cleveland Diagnostics said the funds will be used to expand commercialization of IsoPSA the company s first diagnostic test, designed to enhance early detection of prostate cancer as well as to expand internal infrastructure and operations to support platform development for other tests, including breast and lung cancer. ....

Arnon Chait , Cleveland Diagnostics Inc , Kidney Institute Early , Cleveland Clinic , Cleveland Diagnostics , Glickman Urological , Kidney Institute , Cleveland Diagnostic , கிளீவ்லேண்ட் பரிசோதனை இன்க் , கிட்நீ நிறுவனம் ஆரம்ப , கிளீவ்லேண்ட் சிகிச்சையகம் , கிளீவ்லேண்ட் பரிசோதனை , கிலிக்க்மன் சிறுநீரக , கிட்நீ நிறுவனம் , கிளீவ்லேண்ட் கண்டறியும் ,